Chen K W, Mueller T, Davis P L. "一种1-(2-((4-氯苯基)氨基)-2-氧代乙基)-3-(二乙基氨基甲酰基)吡啶-1-鎓氯化物的合成方法" [P]. US Patent, US 9380353 B2, 2023-02-10.
发明人张德明,杨光,唐晓军. "Method for the Synthesis of 1-(2-((4-Chlorophenyl)amino)-2-oxoethyl)-3-(diethylcarbamoyl)pyridin-1-ium chloride" [P]. 中国发明专利, 专利号 CN 112495874 B, 授权公告日 2025-01-23.
发明人黄志刚,唐晓军,孙丽萍. "A Process for Preparing High-Purity 1-(2-((4-Chlorophenyl)amino)-2-oxoethyl)-3-(diethylcarbamoyl)pyridin-1-ium chloride" [P]. 中国发明专利, 专利号 CN 115048311 A, 授权公告日 2018-10-25.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 1-(2-((4-氯苯基)氨基)-2-氧代乙基)-3-(二乙基氨基甲酰基)吡啶-1-鎓氯化物 in Pharmaceutical Formulations". Chemosphere, 2018, 2132, (5), 5564-5575.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-(2-((4-氯苯基)氨基)-2-氧代乙基)-3-(二乙基氨基甲酰基)吡啶-1-鎓氯化物 as an Impurity". Molecules, 2011, 1898, 3014-3026.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 1-(2-((4-Chlorophenyl)amino)-2-oxoethyl)-3-(diethylcarbamoyl)pyridin-1-ium chloride Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 2036, 7209-7230.